DK1059921T3 - Anvendelse af macrolidforbindelser til behandling af ARDS - Google Patents
Anvendelse af macrolidforbindelser til behandling af ARDSInfo
- Publication number
- DK1059921T3 DK1059921T3 DK99937870T DK99937870T DK1059921T3 DK 1059921 T3 DK1059921 T3 DK 1059921T3 DK 99937870 T DK99937870 T DK 99937870T DK 99937870 T DK99937870 T DK 99937870T DK 1059921 T3 DK1059921 T3 DK 1059921T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- ards
- macrolide compounds
- compounds
- macrolide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP2231A AUPP223198A0 (en) | 1998-03-06 | 1998-03-06 | New use |
PCT/JP1999/001064 WO1999044597A2 (en) | 1998-03-06 | 1999-03-04 | Use of macrolide compounds for the treatment of ards |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1059921T3 true DK1059921T3 (da) | 2003-10-27 |
Family
ID=3806495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99937870T DK1059921T3 (da) | 1998-03-06 | 1999-03-04 | Anvendelse af macrolidforbindelser til behandling af ARDS |
Country Status (15)
Country | Link |
---|---|
US (1) | US6333334B1 (pt) |
EP (1) | EP1059921B1 (pt) |
JP (1) | JP3367105B2 (pt) |
KR (1) | KR100395571B1 (pt) |
CN (1) | CN1133429C (pt) |
AT (1) | ATE244008T1 (pt) |
AU (1) | AUPP223198A0 (pt) |
BR (1) | BR9908796A (pt) |
CA (1) | CA2322027C (pt) |
DE (1) | DE69909257T2 (pt) |
DK (1) | DK1059921T3 (pt) |
ES (1) | ES2196840T3 (pt) |
HK (1) | HK1036406A1 (pt) |
PT (1) | PT1059921E (pt) |
WO (1) | WO1999044597A2 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
JP5619419B2 (ja) * | 2006-09-29 | 2014-11-05 | インファ ソシエテ アノニム | 薬学的組成物用調剤システム及び静脈内投与用キット |
JP2010514790A (ja) * | 2006-12-28 | 2010-05-06 | リメリック バイオファーマ, インコーポレイテッド | 治療処置のための方法および組成物 |
ES2435197T3 (es) | 2007-01-10 | 2013-12-16 | Board Of Regents, The University Of Texas System | Administración mejorada de composiciones de fármacos inmunosupresores para la administración por vía pulmonar |
CN101011414B (zh) * | 2007-01-29 | 2010-07-21 | 褚福明 | 一种肺脑合剂药物 |
US7947733B2 (en) * | 2007-07-31 | 2011-05-24 | Limerick Biopharma | Phosphorylated pyrone analogs and methods |
CN101810633B (zh) * | 2010-03-31 | 2011-12-14 | 湖北丝宝药业有限公司 | 地红霉素在制备治疗慢性非感染性呼吸道疾病药物的用途 |
GB201212773D0 (en) * | 2012-07-18 | 2012-08-29 | Ucl Business Plc | Vascular remodelling |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
GB2248184A (en) * | 1990-09-28 | 1992-04-01 | Fujisawa Pharmaceutical Co | New use of macrolide compounds for active oxygen-mediated diseases |
IE65341B1 (en) * | 1990-11-08 | 1995-10-18 | Fujisawa Pharmaceutical Co | Suspensions containing tricyclic compounds |
WO1992008474A2 (en) * | 1990-11-20 | 1992-05-29 | The National Heart & Lung Institute | Treatment of lung diseases |
US5208241A (en) * | 1991-09-09 | 1993-05-04 | Merck & Co., Inc. | N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity |
GB9218027D0 (en) * | 1992-08-25 | 1992-10-14 | Fisons Plc | Novel method of treatment |
US5290689A (en) * | 1992-09-28 | 1994-03-01 | Merck & Co., Inc. | New cyclic FR-900520 microbial biotransformation agent |
-
1998
- 1998-03-06 AU AUPP2231A patent/AUPP223198A0/en not_active Abandoned
-
1999
- 1999-03-04 EP EP99937870A patent/EP1059921B1/en not_active Expired - Lifetime
- 1999-03-04 ES ES99937870T patent/ES2196840T3/es not_active Expired - Lifetime
- 1999-03-04 JP JP54454999A patent/JP3367105B2/ja not_active Expired - Fee Related
- 1999-03-04 CA CA002322027A patent/CA2322027C/en not_active Expired - Fee Related
- 1999-03-04 WO PCT/JP1999/001064 patent/WO1999044597A2/en active IP Right Grant
- 1999-03-04 PT PT99937870T patent/PT1059921E/pt unknown
- 1999-03-04 AT AT99937870T patent/ATE244008T1/de not_active IP Right Cessation
- 1999-03-04 DK DK99937870T patent/DK1059921T3/da active
- 1999-03-04 KR KR10-2000-7009080A patent/KR100395571B1/ko not_active IP Right Cessation
- 1999-03-04 BR BR9908796-0A patent/BR9908796A/pt not_active Application Discontinuation
- 1999-03-04 US US09/623,595 patent/US6333334B1/en not_active Expired - Fee Related
- 1999-03-04 DE DE69909257T patent/DE69909257T2/de not_active Expired - Lifetime
- 1999-03-04 CN CNB998036676A patent/CN1133429C/zh not_active Expired - Fee Related
-
2001
- 2001-10-17 HK HK01107256A patent/HK1036406A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2322027C (en) | 2009-05-12 |
CA2322027A1 (en) | 1999-09-10 |
CN1292695A (zh) | 2001-04-25 |
EP1059921B1 (en) | 2003-07-02 |
BR9908796A (pt) | 2000-10-31 |
HK1036406A1 (en) | 2002-01-04 |
KR20010041046A (ko) | 2001-05-15 |
WO1999044597A2 (en) | 1999-09-10 |
EP1059921A2 (en) | 2000-12-20 |
KR100395571B1 (ko) | 2003-08-21 |
PT1059921E (pt) | 2003-11-28 |
US6333334B1 (en) | 2001-12-25 |
ATE244008T1 (de) | 2003-07-15 |
AUPP223198A0 (en) | 1998-04-02 |
WO1999044597A3 (en) | 1999-12-29 |
ES2196840T3 (es) | 2003-12-16 |
DE69909257T2 (de) | 2004-02-19 |
JP2001520682A (ja) | 2001-10-30 |
JP3367105B2 (ja) | 2003-01-14 |
DE69909257D1 (de) | 2003-08-07 |
CN1133429C (zh) | 2004-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1056454T3 (da) | Anvendelse af makrolidforbindelser til behandling af glaukom | |
EA200601555A1 (ru) | Замещенные индазол-о-глюкозиды | |
EA200601554A1 (ru) | Замещенные индол-о-глюкозиды | |
NO20006630L (no) | Farmasöytisk sammensetning for behandlingen av diabetes | |
TR200001203T2 (tr) | Yeni birleşik maddeler | |
TR200101412T2 (tr) | Yeni bileşikler. | |
EA200601552A1 (ru) | Замещенные конденсированные гетероциклические с-гликозиды | |
DK2412368T3 (da) | Sammensætning til behandling af ar | |
NO20003233L (no) | 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler | |
TR200201057T2 (tr) | P38 protein kinazı inhibitörleri olarak heteroalkilamino ikameli bisiklik nitrojen heterosaykılları. | |
EA200601553A1 (ru) | Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды | |
PT1169370E (pt) | Solucoes de poliuretano contendo unidades estruturais de alcoxissilano. | |
AP1424A (en) | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens. | |
PE14199A1 (es) | Agonistas de 5-ht1f | |
EE05091B1 (et) | Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid | |
NZ507350A (en) | Semi-synthetic ecteinascidins and use in treatment of tumors | |
NO20005793D0 (no) | Sammensetninger som inneholder organisk mono- eller dinitrat for behandling av impotens | |
WO2001035950A3 (en) | Benzamide therapeutics and methods for treating inflammatory bowel disease | |
ES2243579T3 (es) | Derivados de pirazolopirideno. | |
ID26055A (id) | Senyawa-senyawa hidroksidifenil eter | |
ATE180781T1 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
DK1059921T3 (da) | Anvendelse af macrolidforbindelser til behandling af ARDS | |
SE9604348D0 (sv) | Användning av hydroxyguanidiner | |
TR199903132A3 (tr) | Metalosan bilesiklerinin aktive edici kompozisyonu. | |
DE60116106D1 (de) | Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe |